Zevra Therapeutics (ZVRA) Interest Coverage Ratio Growth (5y) (2019 - 2026)
Zevra Therapeutics (ZVRA) Interest Coverage Ratio Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Zevra Therapeutics | 572.96 Mn | 372.35 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.72% |
| Dec 31, 2025 | -17.64% |
| Sep 30, 2025 | 43.18% |
| Jun 30, 2025 | -78.90% |
| Mar 31, 2025 | 21.04% |
| Dec 31, 2024 | -90.82% |
| Sep 30, 2024 | -42.15% |
| Jun 30, 2024 | -12.26% |
| Mar 31, 2024 | 7.84% |
| Dec 31, 2023 | 33.21% |
| Sep 30, 2023 | -26.16% |
| Jun 30, 2023 | -26.49% |
| Mar 31, 2023 | -11.38% |
| Dec 31, 2022 | 0.54% |
| Sep 30, 2022 | 9.03% |
| Jun 30, 2022 | -19.95% |
| Dec 31, 2021 | -96.31% |
| Sep 30, 2021 | -48.94% |
| Jun 30, 2021 | 19.61% |
| Mar 31, 2021 | 50.69% |